pedicure northampton, ma
twitter facebook rss

mosaic loss of chromosome yrobotic rideable goat

c-Kit+ HSPCs were purified by autoMACS (Miltenyi Biotec) with mouse CD117 MicroBeads (Miltenyi Biotec, catalog 130-091-224). NS, not significant; *P < 0.05 or FDR q < 0.05; **P < 0.01 or FDR q < 0.01; ***P < 0.001 or FDR q < 0.001, ****P < 0.0001 or FDR q < 0.0001, as indicated in the figure legends. ATR inhibition controls aggressive prostate tumors deficient in Y-linked histone demethylase KDM5D. Leukemic blasts were observed in the peripheral blood of all recipient mice (Figure 2C).

It has been reported that mLOY is tightly associated with chromosome instability in human blood cells (3, 8, 12). Immunofluorescence staining showed that both sgSsty1-sgCas9 and sgSsty2-sgCas9 HSPCs had significantly higher levels of H2AX than the sgScr-sgCas9 HSPCs (Figure 1D). Phone: 86.18980606532; Email: chongchen@scu.edu.cn. The truncated Kdm5d cDNA was cloned into retroviral constructs (MSCV-truncated Kdm5d-IRES-GFP), as was AML1-ETO (MSCV-AML1-ETO-IRES-GFP). Sequencing the mouse Y chromosome reveals convergent gene acquisition and amplification on both sex chromosomes. Resistance to docetaxel in prostate cancer is associated with androgen receptor activation and loss of KDM5D expression. **P < 0.01 (log-rank test). Riske CB, et al. By immunofluorescence staining, we found that sgCas9 completely depleted Cas9 in HSPCs (Supplemental Figure 1B). For Kaplan-Meier tumor-free survival curves, log-rank tests were performed. Most of the leukemic cells from either group expressed high levels of c-Kit and myeloid markers Gr-1 and/or Mac-1, but not lymphoid marker CD3 or B220 (Supplemental Figure 4E). sgRNAs were cloned into the pLentiCRISPR-mCherry vector(U6-sgCas9-U6-sgRNA-EFS-mCherry). Moreover, it has been shown that mLOY is tightly associated with multiple hematopoietic and nonhematopoietic human diseases, such as clonal hematopoiesis, leukemia, solid cancers, Alzheimers disease, cardiovascular events, and eventually all-cause mortality (410). Reikvam H, et al. Comet assay. Zhang, Q. QZ performed experiments, analyzed data, and wrote the manuscript. KDM5D has been shown to prevent tumorigenesis, progression, and drug response in prostate cancer and gastric cancer (36, 39, 40). Liu, Y. Further, we wondered whether mouse mLOY AML would recapitulate the molecular signature of human AML with mLOY. Google Scholar, Find articles by

Green, FITC-labeled whole-chromosome probe for Y chromosome; red, Texas redlabeled X chromosome probe for XqA7.3; blue, DAPI-labeled DNA.

And conversely, 35.9% (14/39) of AML1-ETO+ AML were also mLOY (31). The platelet numbers in their peripheral blood were similar (Supplemental Figure 4A). It would be interesting to identify the downstream targets of KDM5D in HSPCs and AML.

Change of human chromosome count distribution with age: evidence for a sex difference. 2022;7(3):e153768.https://doi.org/10.1172/jci.insight.153768.

The gray dotted line shows the growth trend. mLOY promotes CH in mice. *P < 0.05 (log-rank test). The following studies, especially recent genomics studies, provide accumulating evidence establishing mLOY as one of the most frequent chromosome alterations in humans (3, 30). Antibody staining was performed at 4C for 30 minutes with PBS supplemented with 2% FBS. Tyner JW, et al. Fortunately, recent advances in genome editing, including CRISPR/Cas9, have made it possible to remove an entire chromosome precisely (2629). Research ArticleGeneticsHematology Taken together, these results indicate that mLOY in HSPCs promotes AML and CH, partially through loss of Kdm5d. https://doi.org/10.1172/jci.insight.153768, https://doi.org/10.1172/jci.insight.153768DS1, https://www.rdocumentation.org/packages/pheatmap/versions/0.2/topics/pheatmap, American Society for Clinical Investigation. ****P < 0.0001 (2-tailed Mann-Whitney test).

HSPCs (0.5 104) were mixed with 140 L of 1% low-melting-point agarose, and 2 drops were placed on a precoated slide and incubated at 4C for 5 minutes. RNA-seq data of AML patients were downloaded from TARGET AML, TCGA LAML, and BEAT AML (32), transcripts were normalized by DESeq2 (43), and differential expression analysis was performed. Insights into clonal haematopoiesis from 8,342 mosaic chromosomal alterations. (D) Representative photomicrographs of FISH of sgScr-sgCas9, sgSsty1-sgCas9, and sgSsty2-sgCas9 HSPCs before injection (top) and bone marrow cells from recipient mice that developed full-blown AML (BM, bottom). Mice were monitored for clonal hematopoiesis or leukemia by CBC assay, blood smear staining, and flow cytometry. Flow cytometric analysis was performed using FlowJo (RRID: SCR_008520), and flow cytometry was performed on an LSRFortessa (BD Biosciences).

Love MI, et al. At 7 weeks after transplantation, 3 out of 4 sgSsty1-sgCas9; AML1-ETO recipients and 3 out of 6 sgSsty2-sgCas9; AML1-ETO recipients had white blood cell (WBC) counts greater than 40 109/L, while all of the control sgScr-sgCas9; AML1-ETO recipients had WBC counts of approximately 10 109/L. Differences between germline and somatic mutation rates in humans and mice. The sample images were captured using an Olympus BX53 fluorescence microscope after SYBR Green staining. Lastly, we explored the molecular consequences of Kdm5d loss in HSPCs by RNA-seq analyses (Supplemental Figure 6A). Longitudinal changes in the frequency of mosaic chromosome Y loss in peripheral blood cells of aging men varies profoundly between individuals. We found that mLOY led to dramatically increased DNA damage in HSPCs. The tail moment is shown as the mean SD. mLOY, which is associated with AML1-ETO translocation and p53 defects in patients with acute myeloid leukemia (AML), promoted AML in mice. Purified HSPCs were cultured in BCM medium (50% DMEM + 50% IMDM) supplemented with 20% FBS, 2 ng/mL mouse IL-3 (R&D Systems, catalog 403-ML-050), 10 ng/mL mouse IL-6 (R&D Systems, catalog 406-ML-200), and 2 ng/mL mouse stem cell factor (SCF) (R&D Systems, catalog 455-MC-010). (B) RBC counts of recipient mice 9 weeks after transplantation with sgScr-sgCas9, sgSsty1-sgCas9, and sgSsty2-sgCas9 HSPCs. (F) Left: Representative images of comet assay of sgScr and sgKdm5d HSPCs. More importantly, it is strongly associated with aging and numerous aging-related diseases, including cancer (4, 10, 12).

JCI Frequency of trisomy 15 and loss of the Y chromosome in adult leukemia. HSPCs were cultured 1 month in vitro until Cas9 elimination. The distinct mechanisms of DNA damage responses in embryonic and somatic cells (22, 23) might explain the distinct phenotypes of XO mice previously reported (21) and mLOY mice generated in the current study. Among the 29 common downregulated genes was that encoding lysine demethylase 5D (KDM5D), a chromosome Yspecific H3K4 demethylase (Figure 4, AC). Mutational spectrum and dynamics of clonal hematopoiesis in anemia of older individuals. | However, given the complexity of the cell populations involved in AML and CH, further studies are needed to dissect the effects of mLOY in different HSC, lineage-committed progenitors, and other populations in more details. (G) GSEA showing the enrichment of gene signatures (top 200 differentially expressed genes upregulated or downregulated) of mLOY AML patients and mLOY AML mice compared with WT (mLOY and WT patients were derived from the AML1-ETO samples in the TARGET-AML cohort). PubMed Finally, the slides were stained with 10 L DAPI-antifade solution and mounted with a coverslip. Cancer Genome Atlas Research Network, et al. HSPCs were transfected by spinoculation.

By breeding Rosa-Cas9 mice with Trp53/ mice or mCD45.1 mice, we generated Trp53/; Cas9 mice or mCD45.1; Cas9 mice. Consistently with the preleukemic HSPCs in vitro, sgCas9 completely depleted the expression of Cas9 in the resulting sgSsty1-sgCas9; AML1-ETO and sgSsty2-sgCas9; AML1-ETO AML cells (Supplemental Figure 4D). in: Mosaic loss of chromosome Y (mLOY) is the most frequent chromosome alteration in adult males blood cells (1, 2). Mice. Kdm5d cDNA was cloned by PCR from the central nervous system cDNA library of an E14.5 male mouse embryo. chromosome sgSsty1-sgCas9; AML1-ETO and sgSsty2-sgCas9; AML1-ETO mice also had significantly reduced red blood cell (RBC) counts compared with the control mice (Figure 2B).

Peterson LF, et al. RNA-seq analysis. Taken together, our results show that mLOY itself led to DNA damage in HSPCs. The similarity of the transcriptomes of mouse and human AML with mLOY suggested a common molecular mechanism underlying mLOY-driven AML in humans and mice, although the synteny between mouse and human Y chromosomes is poor (34). Komura K, et al. (A) Schematic of CRISPR/Cas9 genome editing of chromosome Y in mouse HSPCs. ***FDR q < 0.001, ****FDR q < 0.0001 (Kruskal-Wallis test). Consistently, gene set enrichment analysis (GSEA) showed that the KEGG_MISMATCH_REPAIR pathway was significantly negatively enriched in sgSsty1-sgCas9 (normalized enrichment score [NES] = 1.47, P = 0.04) and sgSsty2-sgCas9 HSPCs (NES = 1.51, P = 0.03) compared with sgScr-sgCas9 cells (Figure 1F). Copyright: 2022, Zhang et al. Data availability. Leukaemia and loss of Y chromosome. All data are presented as the mean SD, unless otherwise indicated.

****P < 0.0001 (2-tailed Mann-Whitney test). | It is strongly associated with clonal hematopoiesis, hematopoietic malignancies, and other hematopoietic and nonhematopoietic diseases.

Scale bars: 50 m. This is an open access article published under the terms of the Creative Commons Attribution 4.0 International License. Previous meta-analyses showed that approximately half of AML1-ETO+ AML had mLOY (12, 17, 20). (G) Left: Representative images of comet assay of sgSsty1-sgCas9 HSPCs with truncated-Kdm5d overexpression (bottom, the truncated KDM5D is a 659amino acid protein consisting of aa 1695) and vector only (top) was used as a negative control. Jacobs PA, et al. The average survival of sgKdm5d AML mice was 17 days, significantly shorter than that of sgScr AML mice (20 days) (Figure 4D).

The sample images were captured using a ZEISS LSM880 confocal microscope. Mosaic loss of chromosome Y in peripheral blood is associated with shorter survival and higher risk of cancer. RNA was extracted from AML tumor cells (bone marrow cells or splenocytes) or HSPCs with the RNeasy Mini Kit (Qiagen, catalog 74104) following the manufacturers instructions. For in vivo experiments, infected HSPCs (1 106) were transplanted into sublethally irradiated (5.5 or 7 Gy) C57BL/6 female recipient mice by tail vein injection. Right: Plot of comet assay of sgSsty2-sgCas9 HSPCs with truncated-Kdm5d overexpression and vector only. Although mLOY mice were harvested earlier than control mice, their liver and spleen weights were similar to those of the control animals (Supplemental Figure 4, B and C). KDM5D loss mediates the function of mLOY in AML.

Clonal hematopoiesis (CH) is a common aging-related hematopoietic abnormality in which a single hematopoietic stem or progenitor cell gives rise to a substantial proportion of peripheral blood cells or bone marrow cells (hematopoietic stem and progenitor cells, HSPCs) (11). Identification of additional cytogenetic and molecular genetic abnormalities in acute myeloid leukaemia with t(8;21)/AML1-ETO. Study approval. Furthermore, mLOY in leukocytes is a predisposition for hematopoietic malignancies, including acute myeloid leukemia (AML), acute lymphoid leukemia, and myelodysplastic syndrome (4, 16). Scale bars: 50 m. Haitjema S, et al.

Scale bars: 50 m. Here, we generated mLOY in murine hematopoietic stem and progenitor cells (HSPCs) with CRISPR/Cas9 genome editing. The mouse RNA-seq reads were aligned to the reference genome GRCm38 by STAR (42).

Cells were incubated in 0.075 M KCl and then fixed in 3:1 methanol/glacial acetic acid (v/v) and dropped onto microscope slides. in: The target sequence of Cas9 is GATCGGCGACCAGTACGCC; the target sequences of Ssty2 are Ssty2-A ATCACTCAAGAAGAAGAGT and Ssty2-B GGAGCTCCACAGCGATGAG; the target sequences of Ssty1 are Ssty1-A ATCCCTCATGAAGAAGAGG and Ssty1-B GGAGCTCTACAGTGATGAC; and the target sequences of Kdm5d are Kdm5d-A ATGGTACCTACAGAAGTTG and Kdm5d-B GACTTATCTCCTGAAGAAA. PubMed

The comet assay showed that Kdm5d significantly reduced the tail moment of both sgSsty1 and sgSsty2 HSPCs (Figure 4, G and H). Dumanski JP, et al. Address correspondence to: Chong Chen, No. The slides were incubated at 55C for 30 minutes, followed by the addition of 1 L mouse chromosome Y control probe (Empire Genomics, catalog MCENY-10-GR) and 1 L mouse chromosome XqA7.3 probe (Guangzhou Exon Biotechnology, catalog XY-105) to each slide. Right: Plot of H2AX foci per cell, shown as the mean SD. n = 3, 6 (preinjection), n = 2, 4 (12 weeks), n = 2, 4 (21 weeks). Thompson DJ, et al. *FDR q < 0.05 (1-way ANOVA). Whether it also plays a critical role in other mLOY-associated syndromes requires further study. Chromosome Y is a tiny chromosome with very few genes, and the synteny across species is low. *FDR q < 0.05 (1-way ANOVA).

Cytospins were prepared from HSPCs or tumor cell suspensions.

Cancer incidence in women with Turner syndrome in Great Britain: a national cohort study. (February 8, 2022): Dobin A, et al. Forsberg LA, et al.

Green, FITC-labeled whole-chromosome probe for Y chromosome; red, Texas redlabeled X chromosome probe for XqA7.3; blue, DAPI-labeled DNA. Generating mLOY in mouse HSPCs. ****P < 0.0001 (2-tailed Mann-Whitney test).

(D) Left: Representative immunofluorescence images of H2AX foci in sgScr-sgCas9, sgSsty1-sgCas9, and sgSsty2-sgCas9 HSPCs. Scale bars: 10 m. There were no significant differences in the numbers of WBCs and the ratios of B and myeloid cells between the recipients with sgSsty1-sgCas9, sgSsty2-sgCas9, or control sgScr-sgCas9 HSPCs (Supplemental Figure 5, A and B). X and Y chromosome loss as sole abnormality in acute non-lymphocytic leukemia (ANLL). homologous alleles chromosome heterozygous synthesis We used ggplot2 to construct the pie chart of the proportion of mLOY patients among AML patients and mLOY patients among AML patients with AML1-ETO. However, due to the technical challenges to precisely deleting a whole chromosome in somatic cells, functional evidence of mLOY in hematopoietic cells is still missing.

Zhao, L.

The results showed that there were significantly more H2AX foci in the sgKdm5d cells than the control sgScr HSPCs (Figure 4E). | Consistently, accumulating evidence indicates that Turner syndrome patients have a reduced risk of cancer, including hematopoietic malignancies, which is in sharp contrast to the strong association of mLOY with multiple cancers in aging males (24, 25). Loss of Y chromosome in blood is associated with major cardiovascular events during follow-up in men after carotid endarterectomy. mLOY is associated with CH in elderly males (3, 30). In the BEAT AML cohort, 5 of 15 AML with mLOY also had missense mutations in TP53 (Supplemental Figure 3B). in: Among them, up to 60% of AML with t(8;21) (q22;q22) (AML1-ETO) showed mLOY (1720). | Statistics. Allele-specific chromosome removal after Cas9 cleavage in human embryos.

All recipients were monitored by complete blood count (CBC) assay and blood smear for leukemogenesis.

Slides were then submerged in cold working alkaline lysis buffer overnight at 4C, followed by alkaline unwinding for 40 minutes in cold alkaline electrophoresis buffer. (H) Left: Representative images of comet assay of sgSsty2-sgCas9 HSPCs with truncated-Kdm5d overexpression (bottom) and vector only (top). RNA libraries were prepared according to the standard Illumina protocols and used for sequencing. Right: Plot of comet assay of sgSsty1-sgCas9 HSPCs with truncated-Kdm5d overexpression and vector only. | Subramanian A, et al. Similarly, we also observed a strong association in the BEAT AML and The Cancer Genome Atlas (TCGA) LAML cohorts (32, 33) (P = 1.5 1011 and P = 1.1 1015, respectively) (Supplemental Figure 2, B and C). Although all of the control HSPCs had intact Y chromosomes, approximately 15% of sgSsty1-sgCas9 and sgSsty2-sgCas9 HSPCs displayed mLOY, as indicated by negative staining of the chromosome Y probes (Figure 1B). Clinical significance of Y chromosome loss in hematologic disease.

And similarly, human AML with low expression levels of KDM5D also had upregulated expression of the DNA damage checkpoint genes (human: NES = 2.69, P = 0.00, mouse: NES = 1.85, P = 0.00) (Supplemental Figure 6B). Department of Hematology and Institute of Hematology, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, Chengdu, China. To further investigate the mLOY spectrum in AML, we analyzed 3 independent AML cohorts with a total of 620 patients. (A) Venn diagram showing the enrichment of the significantly downregulated genes in mLOY AML patients (top 200) and AML mice. GSEA used statistical approaches to identify significant similarities and differences between 2 given clusters by identifying a prioridefined gene sets (44). Kdm5d-deficient HSPCs and low-KDM5D-expressing AML patients also shared the common leukemia-promoting HALLMARK_MYC_TARGETS_V2 pathway (human: NES = 1.88, P = 0.00; mouse: NES = 2.07, P = 0.00), which was consistent with those in both mouse and human mLOY AML (Figure 2H and Supplemental Figure 6C). Consistent with mLOY HSPCs, mLOY AML cells directly harvested from sick mice displayed significantly higher levels of ongoing DNA damage in leukemic cells, as measured by the comet assay (Figure 2F). Mechanistically, loss of KDM5D, a chromosome Yspecific histone 3 lysine 4 demethylase in both humans and mice, partially recapitulated mLOY in DNA damage and leukemogenesis. Since mLOY led to increased DNA damage in HSPCs, we wondered whether Kdm5d loss might mimic mLOY to promote DNA damage. Chen H, Boutros PC. chromosome Adikusuma F, et al.

White arrows indicate XO cells. *FDR q < 0.05, **FDR q < 0.01 (Kruskal-Wallis test). Thus, Kdm5d loss partially resembled mLOY in HSPCs.

Genetic variants associated with mosaic Y chromosome loss highlight cell cycle genes and overlap with cancer susceptibility. Then the slides were incubated with antibodies against phospho-histone H2A.X (Ser139) (Cell Signaling Technology, catalog 9718S) or Cas9 (S. pyogenes) (E7M1H) XP rabbit mAb (Cell Signaling Technology, catalog 19526S) overnight at 4C, dissolved 1:500 or 1:100 in 1% BSA in PBS.

Sitemap 13

facebook comments:

mosaic loss of chromosome y

Submitted in: madewell petite pants |